Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

st_judes_ensite_precision_mapping_module

Abbott to table $25bn bid for medical device maker St Jude?

August 27, 2015 Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical

Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott …
News
alvogen_drugs_generic

Alvogen buys four-drug portfolio from Pfizer

August 27, 2015 Sales and Marketing Alvogen, Pfizer

Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …
News
cml

NHS restriction of CML treatment in England criticised

August 27, 2015 Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia

Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …
News
md_anderson_cancer_center

Immatics and MD Anderson launch new company to develop ACR therapies

August 27, 2015 Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda

Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …
News
alimta

Lilly defeats Teva in US court over Alimta patent

August 26, 2015 Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer

Eli Lilly has won a case in a US federal court, in a battle over Teva’s attempt to create a …
News
Abasaglar

Lilly and Boehringer launch biosimilar insulin in the UK

August 26, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
News
sean_bohen

AZ appoints Genentech’s Sean Bohen as chief medical officer

August 25, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen

AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.Dr Bohen will …
Appointment
Health secretary Jeremy Hunt

Doctors ‘face jail over pharma payments’

August 24, 2015 Sales and Marketing ABPI, Jeremy Hunt, NHS, PMCPA, bribery, doctor payments, health secretary, transparency

Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …
News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …
News
sun_pharma_hq

Sun Pharma gets FDA approval for acne treatment

August 21, 2015 Medical Communications, Research and Development, Sales and Marketing Sun Pharma. acne treatments, drug approvals

The FDA has approved Sun Pharma’s new acne treatment, Ximino.The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in …
News

Horizon Pharma receives third rejection from Depomed

August 21, 2015 Sales and Marketing Depomed, Horizon Pharma, pharma mergers and acquisitions

Depomed has announced that its board has unanimously rejected Horizon Pharma’s third proposal to buy the California-based company. Following its …
News
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …
News
Sprout sign

Valeant confirms $1bn deal for ‘female viagra’ creator Sprout

August 20, 2015 Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin

Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …
News

Lundbeck sheds 1,000 jobs in £284 million restructure

August 20, 2015 Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …
News
amgen_flag

Amgen agrees to $71m settlement over false advertising

August 19, 2015 Sales and Marketing Amgen, Aranesp, Enbrel

Amgen has reached a $71 million settlement with 48 US states and the District of Columbia, to resolve allegations that …
News
The Gateway to Local Adoption Series

Latest content

Tridem begins phase Ib trial of Parkinson’s disease vaccine

October 13, 2026

Bio-Techne opens GMP small-molecule manufacturing facility in Bristol

October 13, 2026

Trio become latest Symbiosis commercial additions

October 12, 2026

UK immunoglobulin supply faces growing pressure, report warns

October 12, 2026

How will biomarker-led diagnostics reshape respiratory medicine?

October 11, 2026